Amova Asset Management Americas, Inc.

Position in ABSI — Absci Corp

CIK 1480751 NEW YORK, NY

Position in ABSI

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$4,040,322

-$932,153 QoQ

Shares Held

1,346,774

-5.5% QoQ

Ownership

0.864%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Amova Asset Management Americas, Inc. holds $292,344,100 across 16 Biotechnology names. ABSI ranks #10 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BEAM	Beam Therapeutics Inc.	3,825,585	$91,163,690
2	CRSP	CRISPR Therapeutics AG	1,853,875	$88,188,833
3	NTLA	Intellia Therapeutics, Inc.	1,973,061	$25,294,642
4	NRIX	Nurix Therapeutics, Inc.	1,181,146	$18,307,763
5	ARCT	Arcturus Therapeutics Holdings Inc.	2,288,935	$17,670,578
6	RXRX	Recursion Pharmaceuticals, Inc.	5,419,221	$16,637,008
7	PRME	Prime Medicine, Inc.	2,940,793	$10,233,959
8	BNTX	BioNTech SE	77,694	$6,905,442

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,040,322	1,346,774	-5.5%	Shares	Sole	2026-05-07
2025-12-31	$4,972,475	1,424,778	-4.6%	Shares	Sole	2026-02-11
2025-09-30	$4,541,902	1,494,047	+3.2%	Shares	Sole	2025-11-12
2025-06-30	$3,720,033	1,447,484	-3.1%	Shares	Sole	2025-08-11
2025-03-31	$3,749,601	1,493,865	+30.6%	Shares	Sole	2025-05-07
2024-12-31	$2,996,831	1,143,829	+28.5%	Shares	Sole	2025-02-10
2024-09-30	$3,399,204	889,844	+21.6%	Shares	Sole	2024-11-07
2024-06-30	$2,253,814	731,758	+73.9%	Shares	Sole	2024-08-09
2024-03-31	$2,390,212	420,812	—	Shares	Sole	2024-05-02
No filing history on record for this holder in this stock.